NCT06096766 is a clinical trial of blood test in Premature Ovarian Insufficiency, sponsored by Shi Yun.

Who is sponsoring NCT06096766?

NCT06096766 is sponsored by Shi Yun.

What drugs are being tested in NCT06096766?

Interventions in NCT06096766: blood test.

What condition does NCT06096766 study?

NCT06096766 studies Premature Ovarian Insufficiency, Diminished Ovarian Reserve, Biomarker, Copper, Ceruloplasmin, Aging.

Is NCT06096766 still recruiting?

NCT06096766 is currently recruiting now. Last updated 9 December 2024.

Last reviewed 2024-12-09 · How we verify

NCT06096766

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Correlation Between Ovarian Function and Serum Biomarkers

Recruiting now Last updated 9 December 2024

What this trial tests

trial testing blood test in Premature Ovarian Insufficiency in 35 participants. Currently enrolling.

Timeline

25 October 2023

Primary endpoint
11 November 2025

11 November 2025

Quick facts

Lead sponsor	Shi Yun
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	35
Start date	25 October 2023
Primary completion	11 November 2025
Estimated completion	11 November 2025
Sites	1 location across China

Drugs / interventions tested

blood test — full drug profile →

Conditions studied

Premature Ovarian Insufficiency — all drugs for Premature Ovarian Insufficiency →
Diminished Ovarian Reserve — all drugs for Diminished Ovarian Reserve →
Biomarker — all drugs for Biomarker →
Copper — all drugs for Copper →

Sponsor

Shi Yun — full company profile →

Who can join

Adults 18 to 45, female only, with Premature Ovarian Insufficiency or Diminished Ovarian Reserve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to find differences in serum biomarkers between ovarian function and normal individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood test

Trials testing the same drug.

NCT06971289 — Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways · not yet recruiting
NCT06983197 — Iatrogenic Deficiencies in ICU Patients With Prolonged Continuous Renal Replacement Therapy · not yet recruiting
NCT06375889 — Platelet Activation in Delayed Cerebral Ischemia Secondary to Aneurysmal Subarachnoid Hemorrhage · completed
NCT05901207 — Diagnostic and Prognostic Biomarkers for IgG4-related Disease. · unknown
NCT06212505 — EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE · completed

Other recruiting trials for Premature Ovarian Insufficiency

Currently open trials in the same condition.

NCT07510139 — A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insuffi · Phase 1, PHASE2 · active not recruiting
NCT06851754 — Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency · Phase 3 · recruiting
NCT07275671 — Microbiome and Premature Ovarian Insufficiency · recruiting
NCT06645379 — Application of Platelet-rich Plasma (PRP) in Reproductive Medicine · NA · recruiting
NCT06481969 — Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency · NA · recruiting

Other Shi Yun trials

Trials by the same sponsor.

NCT06089395 — The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR) · EARLY_PHASE1 · not yet recruiting
NCT06339489 — The Bone Metabolism Characteristics of Premature Ovarian Insufficiency · recruiting
NCT06102655 — Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06096766 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shi Yun
Last refreshed: 9 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06096766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing